Drawing for PR PHARMAREGS

USPTO serial 99762231

PR PHARMAREGS

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
Examiner
MARTIN, LIEF ANDREW

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: November 25, 2026

Need help with PR PHARMAREGS?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

Office Action issues

The USPTO examiner requires an updated proof of use for your business consulting services and a standard formatting update for your trademark disclaimer.

Owner

  • Jennifer E Schneider

    Matamoras, PA, US

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services in the field of preparing and managing state and federal regulatory licensing applications and compliance filings for pharmaceutical, medical device, and healthcare distribution entities; business consulting services in the field of regulatory compliance and licensing for pharmaceutical, medical device, and healthcare distribution entities.ACTIVEOct 1, 2014
042Software as a service (SAAS) services featuring software for managing, tracking, preparing, and maintaining regulatory compliance, licensing, renewals, and credentialing requirements for pharmaceutical, medical device, and healthcare distribution entities, including automated alerts, document management, trading partner verification, and regulatory reporting.ACTIVEOct 1, 2014

Prosecution history

DateCodeEvent
Aug 25, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 25, 2026GNRTNON-FINAL ACTION E-MAILED
Aug 25, 2026CNRTNON-FINAL ACTION WRITTEN
Aug 21, 2026DOCKASSIGNED TO EXAMINER
Aug 19, 2026MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 19, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Apr 14, 2026NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance